Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
Titel:
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
Auteur:
Zeidan, Amer M Ando, Kiyoshi Rauzy, Odile Turgut, Mehmet Wang, Ming-Chung Cairoli, Roberto Hou, Hsin-An Kwong, Yok-Lam Arnan, Montserrat Meers, Stef Pullarkat, Vinod Santini, Valeria Malek, Kamel Kiertsman, Flavia Niolat, Julie Ramos, Pedro Marques Menssen, Hans D Fenaux, Pierre Miyazaki, Yasushi Platzbecker, Uwe